Fortress Biotech to Participate in A.G.P.’s Annual Virtual Healthcare Conference
Fortress Biotech (Nasdaq: FBIO) announced that Chairman, President and CEO Lindsay A. Rosenwald, M.D., will join a fireside chat at A.G.P.’s Annual Virtual Healthcare Conference on Wednesday, May 20, 2026, starting at 12:20 p.m. ET.
Rhea-AI Summary
Fortress Biotech (Nasdaq: FBIO) announced that Chairman, President and CEO Lindsay A. Rosenwald, M.D., will join a fireside chat at A.G.P.’s Annual Virtual Healthcare Conference on Wednesday, May 20, 2026, starting at 12:20 p.m. ET. Conference registration is available via A.G.P.’s online registration link.
Positive
- None.
Negative
- None.
Details
News Market Reaction – FBIO
On May 18, the day this news came out, FBIO closed 2.90% above the previous close.
Data tracked by StockTitan Argus for the May 18 session.
Key Figures
- Conference date
- May 20, 2026
- Date of A.G.P.’s Annual Virtual Healthcare Conference fireside chat
- Fireside chat time
- 12:20pm ET
- Scheduled start time for Fortress Biotech’s conference session
Historical Context
-
Strong Q1 profit, higher cash, FDA approval and PRV sale benefits.
-
Journey revenue growth, improved losses, positive EBITDA and cash build.
-
Announcement of upcoming Journey Q1 results and conference call timing.
-
Fortress CEO scheduled for virtual royalty company conference fireside chat.
-
Journey expands Emrosi access via third major GPO and broader coverage.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MIAMI, May 18, 2026 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product revenue, equity holdings and dividend and royalty income, today announced that Lindsay A. Rosenwald, M.D., Chairman, President and Chief Executive Officer, will participate in a fireside chat at A.G.P.’s Annual Virtual Healthcare Conference, taking place on Wednesday, May 20, 2026. The fireside chat is scheduled to begin at 12:20pm ET.
To register for the conference, visit the A.G.P. Registration Link.
About Fortress Biotech
Fortress Biotech, Inc. (“Fortress”) is an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product revenue, equity holdings and dividend and royalty income. The company has a portfolio of multiple marketed prescription pharmaceutical products and programs in development at Fortress, at its majority-owned and majority-controlled partners and subsidiaries and at partners and subsidiaries it founded and in which it holds significant minority ownership positions. Fortress’ portfolio is being commercialized and developed for various therapeutic areas including oncology, dermatology, and rare diseases. Fortress’ model is focused on leveraging its significant biopharmaceutical industry expertise and network to further expand and advance the company’s portfolio of product opportunities. Fortress has established partnerships with some of the world’s leading academic research institutions and biopharmaceutical companies to maximize each opportunity to its full potential, including AstraZeneca, City of Hope, Nationwide Children’s Hospital, Columbia University, Dana-Farber Cancer Center and Sentynl Therapeutics. For more information, visit www.fortressbiotech.com.
Company Contact:
Jaclyn Jaffe
Fortress Biotech, Inc.
(781) 652-4500
ir@fortressbiotech.com
Media Relations Contact:
Tony Plohoros
6 Degrees
(908) 591-2839
tplohoros@6degreespr.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.